These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11166495)

  • 1. Reduced dopaminergic activity in depressed suicides.
    Pitchot W; Reggers J; Pinto E; Hansenne M; Fuchs S; Pirard S; Ansseau M
    Psychoneuroendocrinology; 2001 Apr; 26(3):331-5. PubMed ID: 11166495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality.
    Pitchot W; Hansenne M; Gonzalez Moreno A; Pinto E; Reggers J; Fuchs S; Pirard S; Ansseau M
    Psychoneuroendocrinology; 2001 Oct; 26(7):689-96. PubMed ID: 11500250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dopamine in non-depressed patients with a history of suicide attempts.
    Pitchot W; Hansenne M; Ansseau M
    Eur Psychiatry; 2001 Nov; 16(7):424-7. PubMed ID: 11728856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].
    Pitchot W; Hansenne M; Gonzalez Moreno A; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1995; 95(4-5):210-33. PubMed ID: 8525861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suicidal behavior and growth hormone response to apomorphine test.
    Pitchot W; Hansenne M; Moreno AG; Ansseau M
    Biol Psychiatry; 1992 Jun; 31(12):1213-9. PubMed ID: 1391282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-2-adrenoreceptors in depressed suicide attempters: relationship with medical lethality of the attempt.
    Pitchot W; Hansenne M; Pinto E; Reggers J; Fuchs S; Ansseau M
    Neuropsychobiology; 2001; 44(2):91-4. PubMed ID: 11490178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behavior.
    Pitchot W; Reggers J; Pinto E; Hansenne M; Ansseau M
    Neuropsychobiology; 2003; 47(3):152-7. PubMed ID: 12759559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced dopaminergic activity in depressed suicides.
    Watson S; Young AH
    Psychoneuroendocrinology; 2001 Oct; 26(7):757, 759-60. PubMed ID: 11550661
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth hormone response to apomorphine in panic disorder: comparison with major depression and normal controls.
    Pichot W; Hansenne M; Gonzalez Moreno A; Ansseau M
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(6):306-8. PubMed ID: 8527467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of previous antidepressant therapy on the growth hormone response to apomorphine.
    Pitchot W; Hansenne M; Gonzalez Moreno A; Ansseau M
    Neuropsychobiology; 1995; 32(1):19-22. PubMed ID: 7566518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the dopaminergic system in depression: clinical correlates of the apomorphine test].
    Pitchot W; Gonzalez Moreno A; Hansenne M; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1993; 93 Spec No():343-58. PubMed ID: 7916521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between alpha 2-adrenergic function and suicidal behavior in depressed patients.
    Pitchot W; Ansseau M; Gonzalez Moreno A; Wauthy J; Hansenne M; von Frenckell R
    Psychiatry Res; 1994 May; 52(2):115-23. PubMed ID: 7972568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients.
    Monreal JA; Duval F; Mokrani MC; Fattah S; Palao D
    J Psychiatr Res; 2019 May; 112():18-22. PubMed ID: 30836201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.
    McPherson H; Walsh A; Silverstone T
    J Affect Disord; 2003 Sep; 76(1-3):121-5. PubMed ID: 12943941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.
    Brambilla F; Bellodi L; Perna G; Arancio C; Bertani A
    Biol Psychiatry; 1997 Nov; 42(10):889-97. PubMed ID: 9359974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic function in panic disorder: comparison with major and minor depression.
    Pitchot W; Ansseau M; Gonzalez Moreno A; Hansenne M; von Frenckell R
    Biol Psychiatry; 1992 Dec; 32(11):1004-11. PubMed ID: 1467380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopathological correlates of dopaminergic disturbances in major depression.
    Pitchot W; Hansenne M; Moreno AG; von Frenckell R; Ansseau M
    Neuropsychobiology; 1990-1991; 24(4):169-72. PubMed ID: 2135707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior.
    Pitchot W; Ansseau M; Gonzalez Moreno A; Lembreghts M; Hansenne M; Wauthy J; Reel C; Jammaer R; Papart P; Sulon J
    Pharmacopsychiatry; 1995 Oct; 28 Suppl 2():91-2. PubMed ID: 8614706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters.
    Oquendo MA; Waternaux C; Brodsky B; Parsons B; Haas GL; Malone KM; Mann JJ
    J Affect Disord; 2000 Aug; 59(2):107-17. PubMed ID: 10837879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone response to apomorphine in obsessive-compulsive disorder.
    Pitchot W; Hansenne M; Moreno AG; Ansseau M
    J Psychiatry Neurosci; 1996 Nov; 21(5):343-5. PubMed ID: 8973055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.